Filter
352
Text search:
pyrazinamide
Featured
Recommendations
62
New Publications
105
Language
Document type
No document type
255
Guidelines
52
Manuals
16
Studies & Reports
14
Training Material
8
Fact sheets
5
Situation Updates
1
Strategic & Response Plan
1
Countries / Regions
India
24
Western and Central Europe
15
Nepal
11
Eastern Europe
10
Kenya
9
Tanzania
8
Ethiopia
7
South Africa
7
Senegal
6
Uganda
6
Bangladesh
6
Malawi
6
Ukraine
5
Nigeria
4
Philippines
4
Russia
4
Congo, Democratic Republic of
3
Ghana
3
Zambia
3
Rwanda
3
Namibia
3
Lesotho
3
Myanmar / Burma
3
Burkina Faso
2
Zimbabwe
2
Cambodia
2
Benin
2
Eswatini/ Swaziland
2
Botswana
2
Liberia
1
Cameroon
1
Germany
1
Chad
1
Gambia
1
Indonesia
1
Malaysia
1
Mozambique
1
Argentina
1
Brazil
1
Libya
1
Madagascar
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Asia
1
Solomon Islands
1
Bhutan
1
Tajikistan
1
Authors & Publishers
Publication Years
Category
Countries
142
Clinical Guidelines
65
Public Health
7
Women & Child Health
7
Capacity Building
3
Pharmacy & Technologies
3
Key Resources
1
Toolboxes
TB
177
Pharmacy
27
HIV
22
Refugee
6
Polio
5
Caregiver
5
AMR
4
Ebola
3
COVID-19
3
NTDs
3
Conflict
1
Mental Health
1
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Le présent manuel fournit les directives actualisées à l'intention des médecins, infirmiers et laborantins confrontés à la tuberculose multirésistante (TB-MR). Il remplace la version élaborée en 2007 et s’est enrichi de l’expérience pratique de six années. Il s’appuie sur les recomm
...
A survey of prevention, testing and treatment policies and practices
2nd edition.
T The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or sympt
...
National Action Plan: Programmatic Management of Drug Resistance Tuberculosis, Tuberculosis Control Indonesia
WHO recommendations on child health: Guidelines approved by the WHO Guidelines Review Committee
recommended
Updated May 2017
This document is meant to respond to the questions:
■ What health interventions should the child receive and when should s/he receive it?
■ What health behaviours should a mother/caregiver practise (or not practise)?
This document is meant to respond to the questions:
■ What health interventions should the child receive and when should s/he receive it?
■ What health behaviours should a mother/caregiver practise (or not practise)?
Myanmar is one of the world’s 22 high tuberculosis (TB) burden countries, and supporting TB control in Myanmar is a global priority. This report reflects the findings, discussions, conclusions and recommendations of the fourth international review mission of the Myanmar National TB Programme (NTP)
...
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been developed and forms part of the Five Year National Strateg
...
National Tuberculosis Control Program; Mycobacterial Disease Control National AIDS/STD Program
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of Drug Resistant TB" (PMD ...
The term "Programmatic Management of Drug Resistant TB" (PMD ...
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be increased by improving access to the highest-ranked med
...
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
International Journal of Drug Policy 24 (2013) e91-98
The review’s objectives are to review progress in TB control with emphasis on DOTS strategy implementation, summarize the experience, lessons learnt and methods of work and to make recommendations for international donors, technical agencies and the Ministry of Health.
